The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

Exclusion Criteria

• •1. acute ST segment elevation myocardial infarction, stable angina pectoris;
• •2. aspirin allergy or resistance;
• •3. consolidated stroke, chronic obstructive pulmonary disease and other ticagrelor contraindications;
• •4. patients have coagulopathy;
• •5. can not be continued for one year with aspirin and treatment of dual antiplatelet ticagrelor;
• •6. can not complete revascularization;
• •7. NYHA ≥Ⅲ level or left ventricular ejection fraction \<40%;
• •8. severe liver and kidney dysfunction (ALT and AST were more than three times the upper limit of normal, creatinine clearance less than 30ml / min-1.1.72m-2);